The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

Four Case Reports on Treatment of elevated aminotransferase levels with Herbal medicine containing Artemisia capillaris as Principal Component

  • Chu, Hongmin (Department of Internal Medicine and Neuroscience, College of Korean Medicine, Wonkwang University) ;
  • Kim, Cheol-Hyun (Department of Internal Medicine and Neuroscience, College of Korean Medicine, Wonkwang University) ;
  • Kim, Kwang-ho (Department of Internal Medicine and Neuroscience, College of Korean Medicine, Wonkwang University) ;
  • Lee, Young-ung (Department of Internal Medicine and Neuroscience, College of Korean Medicine, Wonkwang University) ;
  • Sung, Kang-keyng (Department of Internal Medicine and Neuroscience, College of Korean Medicine, Wonkwang University) ;
  • Lee, Sang-kwan (Department of Internal Medicine and Neuroscience, College of Korean Medicine, Wonkwang University)
  • Received : 2021.04.22
  • Accepted : 2021.07.28
  • Published : 2021.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Many herbal medications have been used to treat various liver diseases. But the concerns of herbal medicine induced liver injury also existed. In this respect, we would like to report several cases with imporved elevated liver aminotransferase after treating herbal medicine including Artemisia capillaris. Case Reports: We report four patients with elevated aminotransferase levels (ATLs), which indicate hepatocellular damages. After receiving herbal medicines therapy containing Artemisia capillaris as principal component (HMA), the patients' ATLs were improved. In the first case, the patient's ATLs decreased into normal range after administration of HMA, although they have not been improved with hepatotonics for a long period. In the second case, the patient's ATLs have been elevated after taking anticoagulants. The ATLs were improved with HMA without stopping anticoagulants. In the other two cases, the patients' ATLs were also improved after taking HMA. In addition, there were no changes of previous drugs for treating the corresponding underlying diseases and no adverse events during HMA applications. Result and Conclusion: The four patients received the herbal medicine containing Artemisia capillaris as principal component and showed improvement of ATLs. These cases suggest that HMA can be considered as alternative or complementary remedies to improve various liver diseases.

Keywords

References

  1. Wegener, T. (2017). Patterns and trends in the use of herbal products, herbal medicine and herbal medicinal products. International Journal of Complementary & Alternative Medicine. 9(6), 317-319. DOI: 10.15406/ijcam.2017.09.0031
  2. Barnes, P. M., Powell-Griner, E., McFann, K., & Nahin, R. L. (2004). Complementary and alternative medicine use among adults: United States, 2002. Advance data, (343), 1-19.
  3. Xu, J., & Yang, Y. (2009). Traditional Chinese medicine in the Chinese health care system. Health policy (Amsterdam, Netherlands), 90(2-3), 133-139. https://doi.org/10.1016/j.healthpol.2008.09.003
  4. Yoo, TW., Kim, BI., Kim, JB., Kim, DJ., Kim. JW. & Baik SK. (2007). The survey for the actual condition of drug medication and development of health care cost associated with toxic liver injury in Korean: a multicenter study for the detection and the development of nationwide reporting system of toxic liver injry. Korean J Hepatol, 13(1), 34-43.
  5. Ekor M. (2014). The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Frontiers in pharmacology, 4, 177. https://doi.org/10.3389/fphar.2013.00177
  6. Suk, K. T., Kim, D. J., Kim, C. H., Park, S. H., Yoon, J. H. & Kim, Y. S., et al. (2012). A prospective nationwide study of drug-induced liver injury in Korea. The American journal of gastroenterology, 107(9), 1380-1387. https://doi.org/10.1038/ajg.2012.138
  7. Kim, N. H., Jung, H. Y., Cho, S. Y., Park, S. U., Park, J. M., & Ko, C. N. (2011). Liver enzyme abnormalities during concurrent use of herbal and conventional medicines in Korea: a retrospective study. Phytomedicine : international journal of phytotherapy and phytopharmacology, 18(14), 1208-1213. https://doi.org/10.1016/j.phymed.2011.06.026
  8. Lee, J., Shin, J. S., Lee, Y. J., Kim, M. R., Shin, B. C. & Lee, J. H. et al., (2019). Battle Over Herb-Induced Liver Injury: Low Prevalence Confirmed through Secondary Evaluation and Research Team's Clarifying Rebuttal to Unwarranted Public Claims. Journal of alternative and complementary medicine (New York, N.Y.), 25(3), 260-264. https://doi.org/10. 1089/acm.2018.0253 https://doi.org/10.1089/acm.2018.0253
  9. Cho, J. H., Oh, D. S., Hong, S. H., Ko, H., Lee, N. H. & Park, S. E., et al., (2017). A nationwide study of the incidence rate of herb-induced liver injury in Korea. Archives of toxicology, 91(12), 4009-4015. https://doi.org/10.1007/s00204-017-2007-9
  10. Chu H, Park C, Kim C, Sung K, Lee S. Effectiveness and safety of Injinoryung-San -Gagambang (Yinchen Wuling powder) decoctionon stroke patients with elevated serum liverenzymes. Medicine. 2018.97:51(e13577)
  11. Chu, H., Park, C., Kim, C., Sung, K. K., & Lee, S. (2018). Effectiveness and safety of Injinoryung-San-Gagambang (Yinchen Wuling powder) decoction on stroke patients with elevated serum liver enzymes: Three case reports. Medicine, 97(51), e13577. https://doi.org/10.1097/MD.0000000000013577
  12. Stickel, F., & Schuppan, D. (2007). Herbal medicine in the treatment of liver diseases. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 39(4), 293-304. https://doi.org/10.1016/j.dld.2006.11.004
  13. Limdi, J. K., & Hyde, G. M. (2003). Evaluation of abnormal liver function tests. Postgraduate medical journal, 79(932), 307-312. https://doi.org/10.1136/pmj.79.932.307
  14. Kim, H. S., Lee, S. H., Kim, H., Lee, S. H., Cho, J. H. & Lee, H., et al. (2016). Statin-related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea. Journal of clinical pharmacy and therapeutics, 41(3), 266-272. https://doi.org/10.1111/jcpt.12377
  15. Barnes, P. M., Bloom, B., & Nahin, R. L. (2008). Complementary and alternative medicine use among adults and children: United States, 2007. National health statistics reports, (12), 1-23.
  16. Ye, X. F., & He, J. (2010). The bright future of Chinese herbal medicine: only after a twisty road. Contemporary clinical trials, 31(6), 508-509. https://doi.org/10.1016/j.cct.2010.07.007
  17. Lee, W. J., Kim, H. W., Lee, H. Y., & Son, C. G. (2015). Systematic review on herb-induced liver injury in Korea. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 84, 47-54. https://doi.org/10.1016/j.fct.2015.06.004
  18. Lee, J., Shin, J. S., Kim, M. R., Byun, J. H., Lee, S. Y. & Shin, Y. S., et al. (2015). Liver enzyme abnormalities in taking traditional herbal medicine in Korea: A retrospective large sample cohort study of musculoskeletal disorder patients. Journal of ethnopharmacology, 169, 407-412. https://doi.org/10.1016/j.jep.2015.04.048
  19. Chan, K., Zhang, H., & Lin, Z. X. (2015). An overview on adverse drug reactions to traditional Chinese medicines. British journal of clinical pharmacology, 80(4), 834-843. https://doi.org/10.1111/bcp.12598
  20. Liang, Z., Chen, X., Shi, J., Hu H., Xue Y. & Ung C.O.L. (2021). Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials. Chin Med, 16(9), 1-38. https://doi.org/10.1186/s13020-020-00422-x
  21. Zhao, C. Q., Zhou, Y., Ping, J., & Xu, L. M. (2014). Traditional Chinese medicine for treatment of liver diseases: progress, challenges and opportunities. Journal of integrative medicine, 12(5), 401-408. https://doi.org/10.1016/S2095-4964(14)60039-X
  22. Takahashi, H. & Maruyama, K. (1993). Clinical aspects of Kampo treatment for alcoholic liver disease. Igaku no Ayumi (J Clin Exp Med), 167, 811-814. (in Japanese)
  23. Higuchi, K. & Watanabe, A. (2000). Study on liver cancer-preventive effect of juzentaihoto in patients with liver cirrhosis. Methods Kampo Pharmacol, 5, 29-33. (in Japanese)
  24. Okabayashi, T., Mimura, H., Orita, K. (1989). Usefulness of shosaikoto (TJ-9) inthe treatment of postoperative liver dysfunction. Prog Med, 9, 851-855. (in Japanese)
  25. Chtourou, Y., Garoui, E., Boudawara, T., & Zeghal, N. (2013). Therapeutic efficacy of silymarin from milk thistle in reducing manganese-induced hepatic damage and apoptosis in rats. Human & experimental toxicology, 32(1), 70-81. https://doi.org/10.1177/0960327112455674
  26. Lee, I.W., Choi, H.Y., Lee, J.H., Park, S.D., Kim, S.M. & Ku, S.K., et al. (2016). Saeng-Kankunbi-Tang (生肝健脾汤) protects liver against oxidative damage through activation of ERK/Nrf2 pathway. Chinese Journal of Integrative Medicine, 22(8), 619-28. https://doi.org/10.1007/s11655-016-2466-5
  27. Arora, N., & Goldhaber, S. Z. (2006). Anticoagulants and transaminase elevation. Circulation, 113(15), e698-e702. https://doi.org/10.1161/CIRCULATIONAHA.105.603100
  28. Qamar, A., Vaduganathan, M., Greenberger, N. J., & Giugliano, R. P. (2018). Oral Anticoagulation in Patients With Liver Disease. Journal of the American College of Cardiology, 71(19), 2162-2175. https://doi.org/10.1016/j.jacc.2018.03.023
  29. Harrison M. F. (2018). The Misunderstood Coagulopathy of Liver Disease: A Review for the Acute Setting. The western journal of emergency medicine, 19(5), 863-871. https://doi.org/10.5811/westjem.2018.7.37893
  30. Jang, E., Kim, B. J., Lee, K. T., Inn, K. S., & Lee, J. H. (2015). A Survey of Therapeutic Effects of Artemisia capillaris in Liver Diseases. Evidence-based complementary and alternative medicine : eCAM, 2015, 728137. https://doi.org/10.1155/2015/728137
  31. Heo, J. (2009). Donguibogam. Seoul: Bubin PUBLISHERS CO. p142
  32. Lee, J.M.(1964). Dongeuisusebowon. Seoul: Shinil Publishing Co.
  33. Kang, W.S., Lee, J.H. & Wo, H.J. (1999). The effect of Injin and Injinsaryungsangagambang on Liver Cell Viability, Liver Cell Cycle Progression and DNA Damage-induced Apoptosis. J Korean Med, 20(1), 91-105.
  34. ANG, P., GIMLAI, D., WANG, L., ZHANG, S., YE, Z. & LIU, J. et al. (2019). Survival Analysis of Yang Jaundice-Yin-Yang Jaundices-Yin Jaundice Syndrome Differentiation Combined with Western Medicine in the Treatment of Patients with HBV-related Acute-on-chronic Liver Failure. Journal of Traditional Chinese Medicine, 60(7), 582-586